📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
149,939
All-time analysed
42,983
Positive
6,669
Negative
91,579
Neutral
8,640
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
386 announcements match the current filters (relevance ≥ 5).
Paramount Communications to Raise ₹122.64 Crore via Preferential Issue of Shares and Warrants
Paramount Communications (PARACABLES) has approved a significant fundraise of approximately ₹122.64 crores through a preferential allotment. The company will issue 2.20 crore equity shares to non-promoter investors, including reputable funds like Abakkus Diversified Alpha Fund, at ₹42 per share. Additionally, 72 lakh convertible warrants will be issued to promoters at the same price, with 25% payable upfront. This capital infusion is intended to strengthen the balance sheet and support future growth initiatives.
Key Highlights
Preferential issue of 2,19,97,664 equity shares at ₹42 per share, aggregating to ₹92.40 crores.
Issuance of 72,00,000 convertible warrants to promoters at ₹42 per warrant, totaling ₹30.24 crores.
Major participation from Abakkus Diversified Alpha Fund schemes, contributing approximately ₹50 crores.
Issue price of ₹42 is slightly above the regulatory floor price of ₹41.68 per share.
Promoter holding to adjust from 49.14% to 47.01% upon full conversion of warrants and equity issuance.
👀 What to Watch
The participation of high-profile institutional investors like Abakkus is a strong positive signal regarding the company's valuation and growth potential. Investors should monitor the EGM on June 6, 2026, for final approval and subsequent updates on fund utilization.
Paramount Communications to Raise Rs 122.63 Cr via Preferential Issue; Abakkus Fund to Invest
Paramount Communications has approved a significant fundraise of approximately Rs 122.63 crores through the preferential issuance of equity shares and convertible warrants. The company will issue 2.2 crore equity shares at Rs 42 each to institutional and individual investors, with Abakkus Diversified Alpha Fund contributing Rs 50 crores. Additionally, 72 lakh warrants will be issued to promoters at the same price, indicating strong internal commitment. The board also appointed Ms. Rashi Goel as the new Company Secretary and Compliance Officer to strengthen corporate governance.
Key Highlights
Preferential issue of 2,19,97,664 equity shares at Rs 42 each, aggregating to Rs 92.39 crores
Issuance of 72,00,000 convertible warrants to promoters at Rs 42 each, totaling Rs 30.24 crores
Major participation from Abakkus Diversified Alpha Fund (Rs 50 Cr) and Subhkam Ventures (Rs 10 Cr)
Promoter shareholding to settle at 47.01% post-conversion of all warrants from the current 49.14%
Extraordinary General Meeting (EGM) scheduled for June 6, 2026, to seek shareholder approval
👀 What to Watch
The entry of marquee institutional investors like Abakkus at Rs 42 per share serves as a strong valuation benchmark and a vote of confidence. Investors should view this capital infusion as a positive catalyst for future growth and monitor the utilization of proceeds.
Paramount Communications to Raise ₹122.63 Cr via Preferential Issue; Abakkus Fund to Invest
Paramount Communications has approved a significant fundraise of approximately ₹122.63 crore through a preferential issue of equity shares and warrants. The company will issue 2.19 crore equity shares at ₹42 each to non-promoter investors, including a ₹50 crore investment from Sunil Singhania's Abakkus Diversified Alpha Fund. Additionally, promoters will subscribe to 72 lakh convertible warrants at the same price, signaling strong internal confidence. An Extraordinary General Meeting (EGM) is scheduled for June 6, 2026, to seek shareholder approval for this capital infusion.
Key Highlights
Preferential issue of 2,19,97,664 equity shares at ₹42 per share, totaling ₹92.39 crore.
Issuance of 72,00,000 convertible warrants to promoters at ₹42 each, totaling ₹30.24 crore.
Marquee investor Abakkus Diversified Alpha Fund (1 & 2) to invest a combined ₹50 crore.
Promoter shareholding projected at 47.01% on a fully diluted basis post-warrant conversion.
Appointment of Ms. Rashi Goel as Company Secretary and Compliance Officer effective May 13, 2026.
👀 What to Watch
The participation of high-profile institutional investors like Abakkus and the promoters' commitment at ₹42 per share are strong positive indicators. Investors should monitor the EGM outcomes and the company's plans for utilizing the newly raised capital.
Paramount Communications to Raise ₹122.63 Cr via Preferential Issue of Shares and Warrants
Paramount Communications has approved a significant fundraise of approximately ₹122.63 crore through a preferential allotment of equity shares and warrants. The company will issue 2.20 crore equity shares to non-promoter investors at ₹42 each, and 72 lakh convertible warrants to promoters at the same price. Notable institutional participants include Abakkus Diversified Alpha Fund and Singularity Equity Fund, providing a strong institutional backing. The funds are expected to strengthen the balance sheet and support future growth initiatives.
Key Highlights
Preferential issue of 2,19,97,664 equity shares at ₹42 per share, aggregating to ₹92.39 crore.
Issuance of 72,00,000 convertible warrants to promoters at ₹42 each, totaling ₹30.24 crore.
Marquee investors include Abakkus Diversified Alpha Fund (investing ₹50 crore) and Subhkam Ventures.
Promoter shareholding to adjust from 49.14% to 47.01% assuming full conversion of warrants.
Extraordinary General Meeting (EGM) scheduled for June 6, 2026, to obtain shareholder approval.
👀 What to Watch
The participation of high-profile institutional investors like Abakkus is a positive indicator of the company's growth potential. Investors should monitor the company's upcoming EGM and subsequent deployment of capital for expansion or debt reduction.
Parsvnath Developers Enters Corporate Insolvency Resolution Process (CIRP)
Parsvnath Developers Limited has officially entered the Corporate Insolvency Resolution Process (CIRP) following an order from the NCLT New Delhi Bench. The insolvency commencement date was April 30, 2026, with Manoj Kumar Anand appointed as the Interim Resolution Professional (IRP). The resolution process is estimated to conclude by October 27, 2026, within the standard 180-day window. Creditors, including all real estate allottees, have been directed to submit their claims by May 27, 2026.
Key Highlights
NCLT New Delhi ordered CIRP commencement on April 30, 2026, under Petition No. (IB) 468/PB/2024
Manoj Kumar Anand appointed as Interim Resolution Professional (IRP) to manage the company's affairs
Estimated date of closure for the insolvency resolution process is October 27, 2026
Last date for creditors and real estate allottees to submit claims is May 27, 2026
The company's board is effectively suspended as the IRP takes control of management
👀 What to Watch
Equity shareholders should exercise extreme caution as insolvency proceedings typically result in significant erosion of equity value. Investors should monitor the resolution plan and the IRP's progress, but be prepared for potential trading suspensions or delisting.
Paras Defence Re-appoints Auditors and Recommends ₹1 Dividend for FY26
Paras Defence and Space Technologies announced its board meeting outcomes for the fiscal year ended March 31, 2026. The company recommended a final dividend of ₹1 per equity share (20% of face value) and approved the audited financial results for the year. Additionally, the board approved the re-appointment of M/s S M L and Co. LLP as Internal Auditors and M/s Dinesh Jain & Company as Cost Auditors for FY 2026-27. The statutory auditors provided an unmodified opinion on the company's financial statements, indicating no major accounting discrepancies.
Key Highlights
Recommended a final dividend of ₹1 per equity share of ₹5 each for FY 2025-26
Re-appointed M/s S M L and Co. LLP as Internal Auditors for the financial year 2026-27
Re-appointed M/s Dinesh Jain & Company as Cost Auditor for the financial year 2026-27
Statutory Auditors Chaturvedi & Shah LLP issued an unmodified opinion on FY26 financial results
👀 What to Watch
Investors should view the auditor re-appointments as a sign of continuity in internal controls. Monitor the upcoming AGM for the dividend record date and detailed financial performance metrics.
Paras Defence Recommends Final Dividend of ₹1 Per Share for FY 2025-26
Paras Defence and Space Technologies Limited has recommended a final dividend of ₹1 per equity share for the financial year ended March 31, 2026. The dividend is calculated on a face value of ₹5 per share, representing a 20% payout. Alongside the dividend, the board approved the audited standalone and consolidated financial results for FY26 with an unmodified audit opinion. The company also confirmed the re-appointment of its internal and cost auditors for the next financial year.
Key Highlights
Recommended a final dividend of ₹1 per equity share of face value ₹5 each for FY 2025-26
Approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026
Statutory auditors issued an unmodified opinion on the financial statements, ensuring reporting integrity
Re-appointed M/s S M L and Co. LLP as Internal Auditor and M/s Dinesh Jain & Company as Cost Auditor for FY 2026-27
👀 What to Watch
Investors should track the upcoming Annual General Meeting (AGM) for the announcement of the record date to be eligible for the dividend. The consistent dividend payout reflects management's confidence in the company's financial stability within the high-growth defense sector.
Paras Defence Recommends ₹1 Dividend and Approves Audited FY26 Financial Results
Paras Defence and Space Technologies has approved its audited financial results for the quarter and year ended March 31, 2026. The Board recommended a final dividend of ₹1 per equity share (20% of the ₹5 face value), subject to shareholder approval. The company also re-appointed its internal and cost auditors for the 2026-27 fiscal year. The statutory auditors issued an unmodified opinion, indicating that the financial statements present a true and fair view of the company's performance.
Key Highlights
Recommended a final dividend of ₹1 per equity share of ₹5 face value for FY 2025-26.
Approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Statutory auditors (Chaturvedi & Shah LLP) issued an unmodified opinion on the financial results.
Re-appointed M/s SML and Co. LLP as Internal Auditors and M/s Dinesh Jain & Company as Cost Auditors for FY 2026-27.
👀 What to Watch
Investors should review the detailed financial tables for revenue and margin growth trends in the defense sector. The dividend recommendation and clean audit report are positive indicators of corporate governance and cash flow stability.
NCLT Admits Parsvnath Developers into Insolvency Over ₹452 Crore Default
The NCLT New Delhi Bench has admitted Parsvnath Developers into the Corporate Insolvency Resolution Process (CIRP) following a default of ₹452.34 crore. A petition filed by a financial creditor led to the appointment of Mr. Manoj Kumar Anand as the Interim Resolution Professional (IRP). However, the NCLT has temporarily restrained the IRP from taking further steps until a Delhi High Court hearing scheduled for May 25, 2026. The company strongly disputes the debt, claiming total repayments of ₹4,696.01 crore against a disbursed amount of ₹4,153.26 crore.
Key Highlights
NCLT admitted the insolvency petition for a principal default amount of ₹452.34 crore.
Mr. Manoj Kumar Anand has been appointed as the Interim Resolution Professional (IRP).
Company claims to have already repaid ₹4,696.01 crore, exceeding the disbursed principal of ₹4,153.26 crore.
The IRP is currently restrained from taking precipitative steps pending a High Court hearing on May 25, 2026.
👀 What to Watch
Investors should exercise extreme caution as insolvency proceedings typically lead to significant equity dilution or delisting. Monitor the Delhi High Court proceedings on May 25 for any potential stay on the NCLT order.
Paradeep Phosphates Reports 52% PAT Growth in FY26; Revenue Up 29% to ₹21,826 Cr
Paradeep Phosphates (PPL) delivered a robust performance for FY26, with annual revenue growing 28.7% to ₹2,18,263 million and PAT surging 52.2% to ₹10,008 million. The company achieved its highest-ever annual production of 3.7 MMT, reaching 100% capacity utilization across its plants. Strategic backward integration progressed significantly with the commissioning of new Sulphuric Acid plants at Paradeep and Mangalore, increasing capacity by 45%. Despite a marginal 4.7% YoY dip in Q4 PAT, the overall annual margins improved due to better economies of scale and a shift toward value-added NPK grades.
Key Highlights
FY26 Revenue from Operations increased by 28.7% YoY to ₹2,18,263 million.
Annual PAT jumped 52.2% to ₹10,008 million with EBITDA margins expanding to 10.3%.
Total fertilizer sales volume grew 10.2% YoY to 4.21 MMT during the full year.
Commissioned 0.6 MMTPA of Sulphuric Acid capacity, a 45% increase, to enhance backward integration.
Outlined a strategic expansion plan to reach 5.0 MMTPA total capacity by FY29.
👀 What to Watch
Investors should focus on the company's successful backward integration and its transition toward high-margin NPK products which are driving profitability. The long-term growth outlook remains strong supported by the FY29 capacity expansion roadmap and high capacity utilization.
Park Medi World Limited Releases Q4 & FY26 Audited Financial Results Presentation
Park Medi World Limited has officially released its investor presentation for the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. This disclosure, made under SEBI Regulation 30, provides the finalized financial performance for the 2026 fiscal year. The presentation follows the company's transition to a public entity after its Red Herring Prospectus filing in December 2024. Investors can now access detailed operational updates and financial metrics for the hospital group through the stock exchange filings.
Key Highlights
Release of audited standalone and consolidated financial results for the full year ended March 31, 2026
Formal disclosure compliant with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
The presentation provides a comprehensive overview of the group's performance for the 12-month period of FY26
Follows the regulatory framework established during the company's IPO process initiated in late 2024
👀 What to Watch
Investors should review the full presentation on the company's website to analyze key healthcare sector KPIs such as bed occupancy rates and Average Revenue Per Occupied Bed (ARPOB).
Park Medi World FY26 Net Profit Jumps 27% to ₹2,736 Mn; Bed Capacity Hits 3,960
Park Medi World delivered its strongest financial year to date, with FY26 revenue growing 21% to INR 16,794 million and Net Profit rising 27% to INR 2,736 million. The company significantly expanded its footprint, adding 610 beds through acquisitions in Bhatinda and Agra, and commissioning a 350-bed greenfield facility in Panchkula in April 2026. Operational efficiency improved as debtor days dropped from 161 to 129, while the balance sheet remains robust with negligible debt and INR 5,509 million in cash equivalents. Management is focused on integrating these new assets and scaling to a target of 1,500 additional beds by FY28.
Key Highlights
FY26 Revenue grew 21% YoY to INR 16,794 mn, while Q4 Revenue surged 30% YoY to INR 4,604 mn
Annual Net Profit increased 27% to INR 2,736 mn with margins expanding by 83 bps to 16.3%
Bed capacity increased by 20% in FY26 to 3,610 beds, reaching 3,960 beds as of April 2026
Strong liquidity position with INR 5,509 mn in cash and equivalents against negligible term debt of INR 282 mn
Significant operational improvement with debtor days reducing to 129 days from 161 days in the previous year
👀 What to Watch
Investors should note the company's successful balance of aggressive capacity expansion with improving profitability and debt reduction. The stock remains a strong growth play in the healthcare sector as new facilities begin contributing to the bottom line.
Park Medi World FY26 Results: Total Assets Surge to ₹9,167 Mn; Significant Deleveraging Reported
Park Medi World Limited reported a massive expansion in its balance sheet for the financial year ended March 31, 2026, with total assets rising from ₹3,196.28 million to ₹9,167.56 million. The company's equity base saw a substantial jump to ₹8,600.24 million from ₹1,141.86 million, likely driven by a major capital infusion or IPO during the year. Notably, the company significantly deleveraged its balance sheet, reducing non-current borrowings from ₹504.66 million to just ₹47.30 million. High liquidity is evident with cash and bank balances skyrocketing to over ₹3,900 million, positioning the company for aggressive future growth.
Key Highlights
Total Assets grew by 186% YoY to ₹9,167.56 million as of March 31, 2026.
Total Equity increased nearly 7.5x to ₹8,600.24 million, significantly strengthening the capital structure.
Non-current borrowings were reduced by over 90% to ₹47.30 million from ₹504.66 million.
Cash and bank balances surged to ₹3,922 million compared to just ₹5.23 million in the previous year.
Mr. Manoj Khanna transitioned from CHRO to Regional Head, ceasing to be Senior Management Personnel.
👀 What to Watch
The company has achieved a remarkably strong and liquid balance sheet with minimal debt, which is highly favorable for the healthcare sector. Investors should look for management commentary on the deployment of the ₹3,900 million cash reserve for hospital expansions or acquisitions.
Parag Milk Foods Launches Avvatar Protein Cold Coffee; New-Age Segment Grew 91% YoY in FY26
Parag Milk Foods has entered the high-growth ready-to-drink (RTD) protein segment through a strategic partnership with Tetra Pak. The company launched Avvatar Protein Cold Coffee, priced at ₹120, offering 15g of protein per 250ml pack with no added sugar. This launch follows a strong performance in FY26, where the company's new-age business segment, including the Avvatar brand, recorded a 91% year-on-year growth. The product aims to address the 73% protein deficiency in India by integrating nutrition into a familiar daily beverage format.
Key Highlights
Launched India's first RTD protein cold coffee in Tetra Prisma Aseptic 250E packaging priced at ₹120
Each 250ml pack delivers 15g of protein with no added sugar or artificial sweeteners
The Avvatar brand and new-age business segment reported a significant 91% YoY growth in FY26
Strategic collaboration with Tetra Pak for premium, recyclable, and ergonomic packaging to enhance shelf appeal
Targets a massive market opportunity as nearly 73% of the Indian population remains protein deficient
👀 What to Watch
Investors should track the adoption of the Avvatar RTD range as it represents a high-margin expansion into the functional beverage space. The 91% growth in the new-age segment indicates strong brand equity that could drive future valuation re-rating.
Paradeep Phosphates FY26 PAT Surges 52% to ₹1,000 Crore; Revenue Up 29%
Paradeep Phosphates (PPL) delivered a robust performance for FY26, with PAT growing 52% YoY to ₹1,000 crore and revenue rising 29% to ₹21,826 crore. The growth was primarily driven by a 22% increase in NPK sales volumes and achieving nearly 100% capacity utilization. The company strengthened its backward integration by commissioning 0.6 MMTPA of Sulphuric Acid capacity, a 45% increase. Furthermore, PPL's credit rating was upgraded to AA- (stable), reflecting improved financial health and operational efficiency.
Key Highlights
FY26 Revenue from operations increased 29% YoY to ₹21,826 crore, while PAT rose 52% to ₹1,000 crore.
NPK sales volumes (including TSP) grew by 22% YoY to 24.64 LMT, supported by a deep distribution network.
Commissioned new Sulphuric Acid plants at Paradeep and Mangalore, increasing total capacity by 45% to 0.6 MMTPA.
Achieved nearly 100% capacity utilization with total fertilizer production reaching 3.67 MMTPA.
Phos acid capacity expansion from 0.5 MMTPA to 1 MMTPA is on track, with Phase 1 (0.7 MMTPA) expected in FY27.
👀 What to Watch
Investors should note the company's successful execution of backward integration and volume growth in high-margin NPK segments. The ongoing capacity expansions and improved credit rating provide a positive outlook for long-term margin stability and growth.
Paradeep Phosphates Recommends ₹1.50 Dividend and Approves FY26 Audited Results
Paradeep Phosphates Limited (PPL) has recommended a dividend of ₹1.50 per equity share for the financial year ended March 31, 2026. The Board approved the audited financial results for FY26, which incorporate the retrospective impact of the merger with Mangalore Chemicals & Fertilizers Limited (MCFL) from April 1, 2024. Mrs. Rita Menon has been re-appointed as an Independent Director for a second three-year term, ensuring board continuity. The statutory auditors have issued an unmodified opinion on the financial statements, indicating healthy reporting standards.
Key Highlights
Recommended a dividend of ₹1.50 per equity share of ₹10 each for the financial year 2025-26.
Approved audited standalone and consolidated financial results for the year ended March 31, 2026.
Re-appointed Mrs. Rita Menon as an Independent Director for a second term of 3 years effective June 27, 2026.
Financial results restated to include the impact of the MCFL merger from the retrospective appointed date of April 1, 2024.
Statutory auditors BSR & Co. LLP issued an audit report with an unmodified opinion for FY 2025-26.
👀 What to Watch
The dividend recommendation and clean audit report are positive signals for shareholders. Investors should analyze the consolidated performance to gauge the synergy benefits and growth trajectory following the MCFL merger.
Paradeep Phosphates Recommends Rs 1.50 Final Dividend for FY 2025-26
The Board of Paradeep Phosphates has recommended a final dividend of Rs 1.50 per equity share for the financial year ended March 31, 2026. The company's annual financial results now fully incorporate the impact of the merger with Mangalore Chemicals & Fertilizers Limited (MCFL), effective retrospectively from April 1, 2024. Statutory auditors have issued a clean, unmodified opinion on the financial statements. Additionally, the board approved the re-appointment of Mrs. Rita Menon as an Independent Director for a second three-year term.
Key Highlights
Recommended a final dividend of Rs 1.50 per equity share of face value Rs 10 each.
Financial results restated to include MCFL merger impact from the appointed date of April 1, 2024.
Statutory auditors BSR & Co. LLP issued an unmodified audit report for FY 2025-26.
Re-appointed Mrs. Rita Menon as an Independent Director for a second term of 3 years effective June 27, 2026.
👀 What to Watch
Investors should track the record date for the Rs 1.50 dividend and monitor the post-merger operational synergies with MCFL which are now reflected in the audited accounts.
Paradeep Phosphates Reports FY26 Results; Recommends ₹1.50 Dividend
Paradeep Phosphates Limited has approved its audited financial results for the quarter and fiscal year ended March 31, 2026. The Board recommended a dividend of ₹1.50 per equity share, representing a 15% payout on the face value of ₹10. A key development is the retrospective accounting of the merger with Mangalore Chemicals & Fertilizers Limited (MCFL) effective from April 1, 2024, following NCLT approval. Additionally, the company has re-appointed Mrs. Rita Menon as an Independent Director for a second three-year term.
Key Highlights
Recommended a dividend of ₹1.50 per equity share for the financial year 2025-26.
Completed the merger with Mangalore Chemicals & Fertilizers Limited (MCFL) with a retrospective appointed date of April 1, 2024.
Statutory auditors BSR & Co. LLP issued an unmodified opinion on the annual financial results.
Re-appointed Mrs. Rita Menon as an Independent Director for a second term of 3 years starting June 27, 2026.
Financial results for FY25 were restated to reflect the impact of the MCFL scheme of arrangement.
👀 What to Watch
Investors should monitor the consolidated performance post-merger to assess the synergy benefits from the MCFL integration. The dividend recommendation provides a steady return, but the primary focus should remain on the operational efficiency of the combined entity.
Parag Milk Foods FY26 PAT Rises 19% to ₹141 Cr; New Age Business Grows 91%
Parag Milk Foods reported a strong FY26 with record revenue of ₹3,818 crore, up 11% YoY, and a 19% increase in PAT (before exceptional items) to ₹141 crore. Despite a 15% YoY surge in milk procurement prices to ₹42/litre in Q4, the company expanded its gross margins to 28% through a premium product mix and calibrated price hikes. The high-margin 'New Age' segment (Avvatar and Pride of Cows) showed exceptional momentum, growing 91% during the year and now contributing 10% to total turnover. The company also strengthened its balance sheet through equity infusion via warrants and FCCB conversions.
Key Highlights
FY26 Revenue reached ₹3,818 crore (up 11% YoY) with PAT before exceptional items at ₹141 crore (up 19% YoY).
New Age business (Avvatar & Pride of Cows) grew 91% in FY26, contributing 10% to total revenue and hitting ₹100 crore quarterly run-rate.
Q4 FY26 Gross Margins improved by 130 bps YoY to 28.0% despite milk prices rising 15% YoY to ₹42/litre.
Core categories (Ghee, Cheese, Paneer) grew 16% in value for FY26, maintaining a dominant 60% share of the business.
Cash flow from operations stood at ₹149 crore for FY26, while the capital structure was bolstered by equity infusions.
👀 What to Watch
Investors should focus on the company's successful premiumization strategy and the rapid scaling of the high-margin New Age segment. The ability to expand margins despite inflationary milk prices suggests strong pricing power and a favorable shift in product mix.
Parag Milk Foods FY26 PAT Rises 19% to ₹141 Cr; New Age Business Revenue Surges 91%
Parag Milk Foods reported a robust FY26 with consolidated revenue reaching ₹3,818 crore, an 11% YoY increase. Despite a 15% surge in raw milk prices to ₹42 per litre, the company successfully expanded its Q4 gross margins to 28% through a premium product mix and calibrated pricing. The high-margin 'New Age' segment, featuring brands like Avvatar and Pride of Cows, grew 91% annually and now contributes 10% to total turnover. Full-year PAT (before exceptional items) rose 19% to ₹141 crore, supported by a 16% value growth in core categories like Ghee and Cheese.
Key Highlights
FY26 consolidated revenue grew 11% YoY to ₹3,818 crore, with Q4 FY26 PAT rising 23% to ₹32 crore.
New Age business (Avvatar & Pride of Cows) surged 91% in FY26, achieving a consistent ₹100 crore quarterly revenue run rate.
Gross margins improved by 130 bps YoY to 28.0% in Q4 FY26 despite a 15% increase in milk procurement costs.
Core categories (Ghee, Cheese, Paneer) maintained a dominant 60% revenue share with 16% value growth in FY26.
Capital structure was strengthened during the year through equity infusion via preferential warrants and FCCB conversions.
👀 What to Watch
Investors should focus on the company's successful transition toward a high-margin, value-added portfolio which is effectively buffering raw material inflation. The rapid scaling of the 'Avvatar' protein brand suggests strong growth potential in the health and nutrition segment.
